New York, New York

New York, New York 10036-4811

0 studies enrolling now · 3 studies all time

What they study most

Alopecia Areata, Panic Disorder, Schizophrenia

Studies at this site

• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Running, not enrolling
• A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder — Stopped early
• A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia — Completed